Pharmaceutical Strategy for Europe
This initiative aims to modernize the European Union's pharmaceutical legislation to ensure all patients have timely access to affordable and innovative medicines. It focuses on strengthening the resilience of medicine supply chains and promoting research and development within the EU.
The strategy affects pharmaceutical companies, healthcare providers, and patients. It seeks to reduce medicine shortages and improve the competitiveness of the European drug industry.
Documents
A Pharmaceutical Strategy for Europe
position · EN · 2026-05-03
A Pharmaceutical Strategy for Europe
proposal · EN · 2026-05-03
A Pharmaceutical Strategy for Europe
proposal · EN · 2026-05-03
A Pharmaceutical Strategy for Europe
report · EN · 2026-05-03
A Pharmaceutical Strategy for Europe
proposal · EN · 2026-05-03
A Pharmaceutical Strategy for Europe
proposal · EN · 2026-05-03
A Pharmaceutical Strategy for Europe
report · EN · 2026-05-03
A Pharmaceutical Strategy for Europe
report · EN · 2026-05-03
A Pharmaceutical Strategy for Europe
proposal · EN · 2026-05-03
A Pharmaceutical Strategy for Europe
proposal · EN · 2026-05-03
A Pharmaceutical Strategy for Europe
proposal · EN · 2026-05-03
A Pharmaceutical Strategy for Europe
report · EN · 2026-05-03
A Pharmaceutical Strategy for Europe
proposal · EN · 2026-05-03
A Pharmaceutical Strategy for Europe
report · EN · 2026-05-03
A Pharmaceutical Strategy for Europe
report · EN · 2026-05-03
A Pharmaceutical Strategy for Europe
report · EN · 2026-05-03
A Pharmaceutical Strategy for Europe
proposal · EN · 2026-05-03
A Pharmaceutical Strategy for Europe
proposal · EN · 2026-05-03
A Pharmaceutical Strategy for Europe
proposal · EN · 2026-05-03
A Pharmaceutical Strategy for Europe
proposal · EN · 2026-05-03
A Pharmaceutical Strategy for Europe
proposal · EN · 2026-05-03
A Pharmaceutical Strategy for Europe
report · EN · 2026-05-03
A Pharmaceutical Strategy for Europe
proposal · EN · 2026-05-03
A Pharmaceutical Strategy for Europe
report · EN · 2026-05-03
A Pharmaceutical Strategy for Europe
report · EN · 2026-05-03
A Pharmaceutical Strategy for Europe
report · EN · 2026-05-03
A Pharmaceutical Strategy for Europe
report · EN · 2026-05-03
A Pharmaceutical Strategy for Europe
report · EN · 2026-05-03
A Pharmaceutical Strategy for Europe
proposal · EN · 2026-05-03
A Pharmaceutical Strategy for Europe
proposal · EN · 2026-05-03
A Pharmaceutical Strategy for Europe
proposal · EN · 2026-05-03
A Pharmaceutical Strategy for Europe
report · EN · 2026-05-03
A Pharmaceutical Strategy for Europe
report · EN · 2026-05-03
A Pharmaceutical Strategy for Europe
proposal · EN · 2026-05-03
A Pharmaceutical Strategy for Europe
report · EN · 2026-05-03
A Pharmaceutical Strategy for Europe
report · EN · 2026-05-03
A Pharmaceutical Strategy for Europe
proposal · EN · 2026-05-03
A Pharmaceutical Strategy for Europe
report · EN · 2026-05-03
A Pharmaceutical Strategy for Europe
report · EN · 2026-05-03
A Pharmaceutical Strategy for Europe
proposal · EN · 2026-05-03
A Pharmaceutical Strategy for Europe
proposal · EN · 2026-05-03
A Pharmaceutical Strategy for Europe
report · EN · 2026-05-03
A Pharmaceutical Strategy for Europe
report · EN · 2026-05-03
A Pharmaceutical Strategy for Europe
proposal · EN · 2026-05-03
A Pharmaceutical Strategy for Europe
proposal · EN · 2026-05-03
A Pharmaceutical Strategy for Europe
report · EN · 2026-05-03
A Pharmaceutical Strategy for Europe
motion · EN · 2026-05-03
A Pharmaceutical Strategy for Europe
proposal · EN · 2026-05-03
A Pharmaceutical Strategy for Europe
motion · EN · 2026-05-03
A Pharmaceutical Strategy for Europe
report · EN · 2026-05-03